Pharmacists in Michigan - Medicare Status, Address, Contact

8814 Pharmacists found. Showing 121 - 140

Lauren Jenae Buchowski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 W Cheesman Rd, Alma, MI 48801 Phone: 989-576-6010

Raymond Rutkowski, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1686 Wright Ave Ste C, Alma, MI 48801 Phone: 989-968-4003    Fax: 989-968-4005

Cara Waite Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1341 Wright Ave, Alma, MI 48801 Phone: 989-463-6111    Fax: 989-466-0742

Sandra Lynn Horton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1341 Wright Ave, Alma, MI 48801 Phone: 989-463-6111

Amelia Demerath, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1341 Wright Ave, Alma, MI 48801 Phone: 989-463-6111

Matthew Oldrich Morelli, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 W Cheesman Rd, Alma, MI 48801 Phone: 989-576-6010    Fax: 989-576-6065

Gregory Daniel Glowacki, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 W Cheesman Rd, Alma, MI 48801 Phone: 989-576-6010

Mrs. Jolly Joseph, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 N Vandyke, Almont, MI 48315 Phone: 810-798-8501

Brijesh Bhagat, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 N Van Dyke Rd, Rite Aid Pharmacy, Almont, MI 48003 Phone: 810-798-8501    Fax: 810-798-3303

Mrs. Laura Allen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 N Van Dyke Rd, Almont, MI 48003 Phone: 810-798-8501    Fax: 810-798-3303

Mrs. Sherry Lynn Schaedig, ABOC 163492 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 M 32 W, Alpena, MI 49707 Phone: 989-354-7431    Fax: 989-354-7532

Dr. Chima Nwamba Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 M 32 W, Alpena, MI 49707 Phone: 989-354-0731

Dr. Mitchell Gregory May, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 M 32 W, Alpena, MI 49707 Phone: 989-354-8784

Keith Allan Misiak Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2236 Us Highway 23 S, Alpena, MI 49707 Phone: --

Alex Senchuk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1202 W Chisholm St, Alpena, MI 49707 Phone: 989-354-3189

John P. Radocy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 Us Highway 23 S, Alpena, MI 49707 Phone: 989-354-4630

Dr. Sarah Elaine Nowakowski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-358-3950    Fax: 989-358-3720

Mr. Jesse Spicer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 Us Highway 23 S, Alpena, MI 49707 Phone: 989-354-4630

Dr. Michael Lamb, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1202 W Chisholm St, Alpena, MI 49707 Phone: 989-354-3189    Fax: 989-354-3286

Bernard John Purol Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 M 32 W, Alpena, MI 49707 Phone: 989-354-0731

News Archive

Profound immune system discovery opens door to halting destruction of lupus

A researcher funded by the Lupus Research Institute (LRI) has discovered an entirely new and powerful molecular switch that controls the inflammatory response of the immune system.

High ABI may indicate risk for future heart attacks

The prevalence of abnormal ankle-brachial index (ABI) test results among individuals tested for peripheral arterial disease (PAD)—and who are not considered at high risk of a coronary heart event by Framingham-based risk factors—is high and provides another way to identify those who may be at risk for future heart attacks, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

Vanda Pharmaceuticals announces submission of tasimelteon NDA to FDA

Vanda Pharmaceuticals Inc. today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for tasimelteon, a circadian regulator.

ARIAD's oral ridaforolimus improves PFS in patients with metastatic endometrial cancer

Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.

Read more Medical News

› Verified 4 days ago

• «
• 2
• 3
• 4
• 5
• 6
• 7(current)
• 8
• 9
• 10
• 11
• 12
• »